Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
BeOne Medicines NasdaqGS:ONC |
31,50 B | 71,53% | 5/6 | 19,62% | 23,50% | 42,59% | DOWN |
|
CRISPR Therapeutics NasdaqGM:CRSP |
4,26 B | 30,82% | 2/6 | 1267,38% | 57,31% | 80,38% | DOWN |
|
Oculis Holding NasdaqGM:OCS |
1,45 B | -33,93% | 0/0 | 399,17% | -19,95% | 96,09% | UP |
|
MoonLake Immunotherapeutics NasdaqCM:MLTX |
1,22 B | 0,00% | 0/4 | 0,00% | 0,00% | 62,34% | DOWN |
|
Kuros Biosciences SWX:KURN |
0,85 B | 0,00% | 6/6 | 19,96% | 98,00% | 63,89% | DOWN |
|
Idorsia Ltd SWX:IDIA |
0,84 B | 26,66% | 4/6 | 89,56% | 86,65% | 35,54% | DOWN |
|
Basilea Pharmaceutica SWX:BSLN |
0,65 B | 66,74% | 5/6 | 15,54% | 4,29% | 65,40% | UP |
|
ADC Therapeutics NYSE:ADCT |
0,46 B | -7,66% | 2/3 | -15,68% | -283,92% | 119,78% | UP |
|
AC Immune NasdaqGM:ACIU |
0,25 B | -29,31% | 1/6 | 691,84% | -96,01% | 227,73% | DOWN |
|
VectivBio Holding NasdaqGM:VECT |
0,17 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | UP |
|
Molecular Partners SWX:MOLN |
0,12 B | -32,25% | 2/6 | -100,00% | -347,15% | 186,62% | DOWN |
|
Polyphor SWX:POLN |
0,02 B | 0,00% | 0,00% | 0,00% | 0,00% | DOWN | |
|
Relief Therapeutics Holding SWX:MMTX |
0,01 B | 42,95% | 0/0 | 0,00% | 0,00% | -100,00% | DOWN |
|
Mymetics OTCPK:MYMX |
0,00 B | 0,00% | 1/2 | 0,00% | 0,00% | 0,00% | DOWN |
